Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam Tablets in Uncontrolled Partial-Onset Seizures (Phase III, CTR20202124)
CTR20202124Phase 3Completed
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brivaracetam in epilepsy, sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Started Oct 2020; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on CTR20202124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202124.